Corona research at BESSY II: Two days of measuring operation to find the right key

Schematic representation of the coronavirus protease. The enzyme comes as a dimer consisting of two identical molecules. A part of the dimer is shown in colour (green and purple), the other in grey. The small molecule in yellow binds to the active centre of the protease and could be used as blueprint for an inhibitor.

Schematic representation of the coronavirus protease. The enzyme comes as a dimer consisting of two identical molecules. A part of the dimer is shown in colour (green and purple), the other in grey. The small molecule in yellow binds to the active centre of the protease and could be used as blueprint for an inhibitor. © Helena Tabermann/HZB

Filmclip: At BESSY II, the main protease of SARS-CoV2 has been decoded. This might help to develop drugs. © HGmedien/HZB

01:11

The Berlin Synchrotron Source BESSY II of the Helmholtz-Zentrum Berlin (HZB) will resume operation for two days. Scientists intend to use the intense X-ray radiation from BESSY II to search for active substances against the corona virus SARS-CoV2. Almost two hundred samples from an important protein of the virus will be examined in the coming hours. The samples are saturated with different molecules that could be used as components of active substances. The analyses will show whether certain molecules can dock particularly well to the protein molecule and thus hinder the reproduction of the virus. These molecules are best candidates as components of a future drug. 

In February, Prof. Dr. Rolf Hilgenfeld (University of Lübeck) and his team had already decoded the structure of a protein of the SARS-CoV-2 virus at the X-ray source BESSY II. It was the main protease, which is involved in the reproduction of the virus. The three-dimensional shape of this protease is crucial for its function, in particular the environment of so-called active centres in the molecule. 

Major Breakthrough: 3D-Structure of viral main protease decoded at BESSY II

Measurements at the MX stations at BESSY II have elucidated the protease's 3D structure in detail. "This was a major breakthrough," says Dr. Manfred Weiss, who heads the MX team at BESSY II. "As soon as the 3D structure is known, we can specifically look for active substances that block this protease and thus prevent the viruses from multiplying," explains Weiss.

Systematic search for fitting molecules

The MX team has developed a method that now enables the systematic search for active substances: fragment screening. A suitable drug must have components or fragments that are precisely tailored to the 3D structure of the protein. They must fit like a key in a lock in order to obstruct the function of the protein.

A fragment library consists of hundreds of molecule groups that could be used as components of active substances. And just as a burglar uses a lock pick to gradually find out what the perfect key for the safe looks like, research can use fragment screening.  Different molecules are gradually being tested until the best components for a suitable drug are identified.

Nearly 200 samples are being analysed

Dr. Linlin Zhang from the Lübeck team has now produced a large number of protein crystals and impregnated each sample with a different compound from the fragment library. These samples will now be investigated at BESSY II.

From the results, it can be determined which fragments dock at all in the active centre of the viral protease. These fragments can then be considered as components for a drug.  "Of course, further experiments and series of measurements will have to be carried out afterwards, both in animal models and in human cell cultures," said Weiss. But in view of the infinite number of chemical compounds, this systematic pre-selection of promising building blocks offers the chance of enormous acceleration.

"We initially started with the smaller library of 96 fragments," says Weiss. "But if there are not enough hits, we can also work with a much larger library".

arö


You might also be interested in

  • BESSY II: Molecular orbitals determine stability
    Science Highlight
    07.02.2024
    BESSY II: Molecular orbitals determine stability
    Carboxylic acid dianions (fumarate, maleate and succinate) play a role in coordination chemistry and to some extent also in the biochemistry of body cells. An HZB team at BESSY II has now analysed their electronic structures using RIXS in combination with DFT simulations. The results provide information not only on electronic structures but also on the relative stability of these molecules which can influence an industry's choice of carboxylate dianions, optimizing both the stability and geometry of coordination polymers.
  • BESSY II: Local variations in the structure of High-Entropy Alloys
    Science Highlight
    30.01.2024
    BESSY II: Local variations in the structure of High-Entropy Alloys
    High-entropy alloys can withstand extreme heat and stress, making them suitable for a variety of specific applications. A new study at the X-ray synchrotron radiation source BESSY II has now provided deeper insights into the ordering processes and diffusion phenomena in these materials. The study involved teams from HZB, the Federal Institute for Materials Research and Testing, the University of Latvia and the University of Münster.
  • Focused ion beam technology: a single tool for a wide range of applications
    Science Highlight
    11.01.2024
    Focused ion beam technology: a single tool for a wide range of applications
    Processing materials on the nanoscale, producing prototypes for microelectronics or analysing biological samples: The range of applications for finely focused ion beams is huge. Experts from the EU collaboration FIT4NANO have now reviewed the many options and developed a roadmap for the future. The article, published in “Applied Physics Review”, is aimed at students, users from industry and science as well as research policy makers.